Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model

Vaccine

Volumn 27, Issue 11, 2009, Pages 1758-1763

  Hu, Hui ^a,b   Huang, Xianqing ^b   Tao, Ling ^a   Huang, Yi ^a   Cui, Bao an ^b   Wang, Hanzhong ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b HENAN AGRICULTURAL UNIVERSITY   (China)

Author keywords

DNA vaccine; Immunization routes; Nucleocapsid protein; SARS CoV

Indexed keywords

DNA VACCINE; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA IMMUNIZATION; FEMALE; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; T LYMPHOCYTE ACTIVATION; VIRUS NUCLEOCAPSID;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CAPSID; CELL PROLIFERATION; DNA, VIRAL; ELECTROPORATION; FEMALE; IMMUNITY, CELLULAR; INJECTIONS, INTRAMUSCULAR; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPHOCYTES; MICE; MICE, INBRED BALB C; PLASMIDS; SALMONELLA TYPHIMURIUM; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VACCINES, ATTENUATED; VACCINES, DNA; VIRAL VACCINES;

EID: 60849099311     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.021     Document Type: Article

References (44)

1. Stadler K., Masignani V., Eickmann M., Becker S., Abrignani S., Klenk H.D., et al. SARS-beginning to understand a new virus. Nat Rev Microbiol 1 3 (2003) 209-218
2. Fouchier R.A., Kuiken T., Schutten M., van Amerongen G., van Doornum G.J., van den Hoogen B.G., et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423 6937 (2003) 240
3. Ksiazek T.G., Erdman D., Goldsmith C.S., Zaki S.R., Peret T., Emery S., et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348 20 (2003) 1953-1966
4. Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348 20 (2003) 1967-1976
5. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361 9366 (2003) 1319-1325
6. Marra M.A., Jones S.J., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S., et al. The Genome sequence of the SARS-associated coronavirus. Science 300 5624 (2003) 1399-1404
7. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300 5624 (2003) 1394-1399
8. Christian M.D., Poutanen S.M., Loutfy M.R., Muller M.P., and Low D.E. Severe acute respiratory syndrome. Clin Infect Dis 38 10 (2004) 1420-1427
9. Liu C., Kokuho T., Kubota T., Watanabe S., Inumaru S., Yokomizo Y., et al. DNA mediated immunization with encoding the nucleoprotein gene of porcine transmissible gastroenteritis virus. Virus Res 80 1-2 (2001) 75-82
10. Narayanan K., Chen C.J., Maeda J., and Makino S. Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J Virol 77 5 (2003) 2922-2927
11. Kuo L., and Masters P.S. Genetic evidence for a structural interaction between the carboxy termini of the membrane and nucleocapsid proteins of mouse hepatitis virus. J Virol 76 10 (2002) 4987-4999
12. Parker M.M., and Masters P.S. Sequence comparison of the N genes of five strains of the coronavirus mouse hepatitis virus suggests a three domain structure for the nucleocapsid protein. Virology 179 1 (1990) 463-468
13. Hohdatsu T., Yamato H., Ohkawa T., Kaneko M., Motokawa K., Kusuhara H., et al. Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP. Vet Microbiol 97 1-2 (2003) 31-44
14. Anton I.M., Gonzalez S., Bullido M.J., Corsin M., Risco C., Langeveld J.P., et al. Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies. Virus Res 46 1-2 (1996) 111-124
15. Chang M.S., Lu Y.T., Ho S.T., Wu C.C., Wei T.Y., Chen C.J., et al. Antibody detection of SARS-CoV spike and nucleocapsid protein. Biochem Biophys Res Commun 314 4 (2004) 931-936
16. Chen Z., Pei D., Jiang L., Song Y., Wang J., Wang H., et al. Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin Chem 50 6 (2004) 988-995
17. Huang L.R., Chiu C.M., Yeh S.H., Huang W.H., Hsueh P.R., Yang W.Z., et al. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA. J Med Virol 73 3 (2004) 338-346
18. Zhu M.S., Pan Y., Chen H.Q., Shen Y., Wang X.C., Sun Y.J., et al. Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine. Immunol Lett 92 3 (2004) 237-243
19. Tan Y.J., Goh P.Y., Fielding B.C., Shen S., Chou C.F., Fu J.L., et al. Profiles of antibody responses against severe acute respiratory syndrome coronavirus recombinant proteins and their potential use as diagnostic markers. Clin Diagn Lab Immunol 11 2 (2004) 362-371
20. Timani K.A., Ye L., Zhu Y., Wu Z., and Gong Z. Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS. J Clin Virol 30 4 (2004) 309-312
21. Wang Z., Yuan Z., Matsumoto M., Hengge U.R., and Chang Y.F. Immune responses with DNA vaccines encoded different gene fragments of severe acute respiratory syndrome coronavirus in BALB/c mice. Biochem Biophys Res Commun 327 1 (2005) 130-135
22. Gao W., Tamin A., Soloff A., D'Aiuto L., Nwanegbo E., Robbins P.D., et al. Effects of a SARS-associated coronavirus vaccine in monkeys. Lancet 362 9399 (2003) 1895-1896
23. Kim T.W., Lee J.H., Hung C.F., Peng S., Roden R., Wang M.C., et al. Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 78 9 (2004) 4638-4645
24. Jin H., Xiao C., Chen Z., Kang Y., Ma Y., Zhu K., et al. Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. Biochem Biophys Res Commun 328 4 (2005) 979-986
25. Okada M., Takemoto Y., Okuno Y., Hashimoto S., Yoshida S., Fukunaga Y., et al. The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice. Vaccine 23 17-18 (2005) 2269-2272
26. Gilbert S.C., Moorthy V.S., Andrews L., Pathan A.A., McConkey S.J., Vuola J.M., et al. Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis. Vaccine 24 21 (2006) 4554-4561
27. Girard M.P., Osmanov S.K., and Kieny M.P. A review of vaccine research and development: the human immunodeficiency virus (HIV). Vaccine 24 19 (2006) 4062-4081
28. LeBlanc R., Vasquez Y., Hannaman D., and Kumar N. Markedly enhanced immunogenicity of a Pfs25 DNA-based malaria transmission-blocking vaccine by in vivo electroporation. Vaccine 26 2 (2008) 185-192
29. Scheerlinck J.P., Karlis J., Tjelle T.E., Presidente P.J., Mathiesen I., and Newton S.E. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 22 13-14 (2004) 1820-1825
30. Dougan G., Hormaeche C.E., and Maskell D.J. Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system. Parasite Immunol 9 2 (1987) 151-160
31. Ashby D., Leduc I., Lauzon W., Lee B.C., Singhal N., and Cameron D.W. Attenuated Salmonella typhimurium SL3261 as a vaccine vector for recombinant antigen in rabbits. J Immunol Methods 299 1-2 (2005) 153-164
32. Benyacoub J., Hopkins S., Potts A., Kelly S., Kraehenbuhl J.P., Curtiss R., et al. The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice. Infect Immun 67 7 (1999) 3674-3679
33. Flo J., Tisminetzky S., and Baralle F. Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice. Vaccine 19 13-14 (2001) 1772-1782
34. Darji A., zur Lage S., Garbe A.I., Chakraborty T., and Weiss S. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol 27 4 (2000) 341-349
35. Harrison J.A., Villarreal-Ramos B., Mastroeni P., Demarco de Hormaeche R., and Hormaeche C.E. Correlates of protection induced by live Aro-Salmonella typhimurium vaccines in the murine typhoid model. Immunology 90 4 (1997) 618-625
36. Froebel K.S., Pakker N.G., Aiuti F., Bofill M., Choremi-Papadopoulou H., Economidou J., et al. Standardisation and quality assurance of lymphocyte proliferation assays for use in the assessment of immune function. European Concerted Action on Immunological and Virological Markers of HIV Disease Progression. J Immunol Methods 227 1-2 (1999) 85-97
37. De Rose R., Tennent J., McWaters P., Chaplin P.J., Wood P.R., Kimpton W., et al. Efficacy of DNA vaccination by different routes of immunisation in sheep. Vet Immunol Immunopathol 90 1-2 (2002) 55-63
38. Hu H., Lu X., Tao L., Bai B., Zhang Z., Chen Y., et al. Induction of specific immune responses by severe acute respiratory syndrome coronavirus spike DNA vaccine with or without interleukin-2 immunization using different vaccination routes in mice. Clin Vaccine Immunol 14 7 (2007) 894-901
39. Otten G.R., Schaefer M., Doe B., Liu H., Megede J.Z., Donnelly J., et al. Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation. Vaccine 24 21 (2006) 4503-4509
40. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164 9 (2000) 4635-4640
41. Otten G., Schaefer M., Doe B., Liu H., Srivastava I., zur Megede J., et al. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 22 19 (2004) 2489-2493
42. Xiang R., Lode H.N., Chao T.H., Ruehlmann J.M., Dolman C.S., Rodriguez F., et al. An autologous oral DNA vaccine protects against murine melanoma. Proc Natl Acad Sci USA 97 10 (2000) 5492-5497
43. Woo P.C., Wong L.P., Zheng B.J., and Yuen K.Y. Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium. Vaccine 19 20-22 (2001) 2945-2954
44. Shata M.T., Reitz Jr. M.S., DeVico A.L., Lewis G.K., and Hone D.M. Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector. Vaccine 20 3-4 (2001) 623-629